Leigh Revers
Keine laufenden Positionen mehr
Profil
Leigh Revers is the founder of Molecular Templates, Inc. which was founded in 2000.
Dr. Revers held the title of Vice President-Research & Development at Molecular Templates, Inc. from 2009 to 2010.
Dr. Revers also founded Molecular Templates, Inc. in 2000.
Dr. Revers's former job was as a Principal at Hospital for Sick Children Foundation.
Dr. Revers received a doctorate degree from the University of Oxford.
Ehemalige bekannte Positionen von Leigh Revers
| Unternehmen | Position | Ende |
|---|---|---|
| Hospital for Sick Children Foundation | Corporate Officer/Principal | - |
| MOLECULAR TEMPLATES, INC. | Gründer | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Gründer | - |
Ausbildung von Leigh Revers
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
| Hospital for Sick Children Foundation | Miscellaneous |
